APO RESEARCH · REPORT
Jet Lag Treatment
Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.
Product & engineering
Understand the product.
Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.
The medication includes Nonbenzodiazepines, Benzodiazepines, Melatonin and some other drugs.
In our report, the measurement level is unit, which means that each unit is the same as each pill.
Selected research
Industry Research
Jet Lag Treatment Industry Research Report 2026
Market perspective
Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.
The medication includes Nonbenzodiazepines, Benzodiazepines, Melatonin and some other drugs.
In our report, the measurement level is unit, which means that each unit is the same as each pill.
Read the full market overview
North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.The key manufacturers are Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan, Clinigen Group, Vanda Pharma etc. Top 3 companies occupied about 22% market share.
Report Scope
This report quantifies the global Jet Lag Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Jet Lag Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Jet Lag Treatment Market by Company
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Jet Lag Treatment Segment by Type
Prescription
OTC
Jet Lag Treatment Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online
Jet Lag Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Jet Lag Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Jet Lag Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Jet Lag Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Jet Lag Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription
- OTC
Applications
- Hospital Pharmacies
- Retail Pharmacies
- Online
Companies covered
- Teva
- Mylan
- Nature’s Bounty
- Otsuka Pharma (Pharmavite)
- Boiron
- Miers Laboratories
- Genexa
- Homeocan
- Clinigen Group
- Vanda Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Jet Lag Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Prescription
- 2.2.3 OTC
- 2.3 Jet Lag Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Retail Pharmacies
- 2.3.4 Online
- 2.4 Assumptions and Limitations
3 Jet Lag Treatment Breakdown Data by Type
- 3.1 Global Jet Lag Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Jet Lag Treatment Forecasted Market Size by Type (2027-2032)
4 Jet Lag Treatment Breakdown Data by Application
- 4.1 Global Jet Lag Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Jet Lag Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Jet Lag Treatment Market Perspective (2021-2032)
- 5.2 Global Jet Lag Treatment Growth Trends by Region
- 5.2.1 Global Jet Lag Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Jet Lag Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Jet Lag Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Jet Lag Treatment Market Dynamics
- 5.3.1 Jet Lag Treatment Industry Trends
- 5.3.2 Jet Lag Treatment Market Drivers
- 5.3.3 Jet Lag Treatment Market Challenges
- 5.3.4 Jet Lag Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Jet Lag Treatment Players by Revenue
- 6.1.1 Global Top Jet Lag Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Jet Lag Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Jet Lag Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Jet Lag Treatment Head Office and Area Served
- 6.4 Global Jet Lag Treatment Players, Product Type & Application
- 6.5 Global Jet Lag Treatment Manufacturers Established Date
- 6.6 Global Jet Lag Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Jet Lag Treatment Market Size (2021-2032)
- 7.2 North America Jet Lag Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Jet Lag Treatment Market Size by Country (2021-2026)
- 7.4 North America Jet Lag Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Jet Lag Treatment Market Size (2021-2032)
- 8.2 Europe Jet Lag Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Jet Lag Treatment Market Size by Country (2021-2026)
- 8.4 Europe Jet Lag Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Jet Lag Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Jet Lag Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Jet Lag Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Jet Lag Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Jet Lag Treatment Market Size (2021-2032)
- 10.2 South America Jet Lag Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Jet Lag Treatment Market Size by Country (2021-2026)
- 10.4 South America Jet Lag Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Jet Lag Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Jet Lag Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Jet Lag Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Jet Lag Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Teva
- 12.1.1 Teva Company Information
- 12.1.2 Teva Business Overview
- 12.1.3 Teva Revenue in Jet Lag Treatment Business (2021-2026)
- 12.1.4 Teva Jet Lag Treatment Product Portfolio
- 12.1.5 Teva Recent Developments
- 12.2 Mylan
- 12.2.1 Mylan Company Information
- 12.2.2 Mylan Business Overview
- 12.2.3 Mylan Revenue in Jet Lag Treatment Business (2021-2026)
- 12.2.4 Mylan Jet Lag Treatment Product Portfolio
- 12.2.5 Mylan Recent Developments
- 12.3 Nature’s Bounty
- 12.3.1 Nature’s Bounty Company Information
- 12.3.2 Nature’s Bounty Business Overview
- 12.3.3 Nature’s Bounty Revenue in Jet Lag Treatment Business (2021-2026)
- 12.3.4 Nature’s Bounty Jet Lag Treatment Product Portfolio
- 12.3.5 Nature’s Bounty Recent Developments
- 12.4 Otsuka Pharma (Pharmavite)
- 12.4.1 Otsuka Pharma (Pharmavite) Company Information
- 12.4.2 Otsuka Pharma (Pharmavite) Business Overview
- 12.4.3 Otsuka Pharma (Pharmavite) Revenue in Jet Lag Treatment Business (2021-2026)
- 12.4.4 Otsuka Pharma (Pharmavite) Jet Lag Treatment Product Portfolio
- 12.4.5 Otsuka Pharma (Pharmavite) Recent Developments
- 12.5 Boiron
- 12.5.1 Boiron Company Information
- 12.5.2 Boiron Business Overview
- 12.5.3 Boiron Revenue in Jet Lag Treatment Business (2021-2026)
- 12.5.4 Boiron Jet Lag Treatment Product Portfolio
- 12.5.5 Boiron Recent Developments
- 12.6 Miers Laboratories
- 12.6.1 Miers Laboratories Company Information
- 12.6.2 Miers Laboratories Business Overview
- 12.6.3 Miers Laboratories Revenue in Jet Lag Treatment Business (2021-2026)
- 12.6.4 Miers Laboratories Jet Lag Treatment Product Portfolio
- 12.6.5 Miers Laboratories Recent Developments
- 12.7 Genexa
- 12.7.1 Genexa Company Information
- 12.7.2 Genexa Business Overview
- 12.7.3 Genexa Revenue in Jet Lag Treatment Business (2021-2026)
- 12.7.4 Genexa Jet Lag Treatment Product Portfolio
- 12.7.5 Genexa Recent Developments
- 12.8 Homeocan
- 12.8.1 Homeocan Company Information
- 12.8.2 Homeocan Business Overview
- 12.8.3 Homeocan Revenue in Jet Lag Treatment Business (2021-2026)
- 12.8.4 Homeocan Jet Lag Treatment Product Portfolio
- 12.8.5 Homeocan Recent Developments
- 12.9 Clinigen Group
- 12.9.1 Clinigen Group Company Information
- 12.9.2 Clinigen Group Business Overview
- 12.9.3 Clinigen Group Revenue in Jet Lag Treatment Business (2021-2026)
- 12.9.4 Clinigen Group Jet Lag Treatment Product Portfolio
- 12.9.5 Clinigen Group Recent Developments
- 12.10 Vanda Pharma
- 12.10.1 Vanda Pharma Company Information
- 12.10.2 Vanda Pharma Business Overview
- 12.10.3 Vanda Pharma Revenue in Jet Lag Treatment Business (2021-2026)
- 12.10.4 Vanda Pharma Jet Lag Treatment Product Portfolio
- 12.10.5 Vanda Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst